Yoshiyuki Ohsugi

4.8k total citations
84 papers, 4.0k citations indexed

About

Yoshiyuki Ohsugi is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Yoshiyuki Ohsugi has authored 84 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Immunology, 28 papers in Oncology and 21 papers in Molecular Biology. Recurrent topics in Yoshiyuki Ohsugi's work include Cytokine Signaling Pathways and Interactions (16 papers), T-cell and B-cell Immunology (12 papers) and Monoclonal and Polyclonal Antibodies Research (9 papers). Yoshiyuki Ohsugi is often cited by papers focused on Cytokine Signaling Pathways and Interactions (16 papers), T-cell and B-cell Immunology (12 papers) and Monoclonal and Polyclonal Antibodies Research (9 papers). Yoshiyuki Ohsugi collaborates with scholars based in Japan, United States and France. Yoshiyuki Ohsugi's co-authors include Masahiko Mihara, Tadamitsu Kishimoto, Yasuo Koishihara, Norihiro Nishimoto, Kazuyuki Yoshizaki, Koh Sato, Hideyuki Okano, Tetsuji Naka, Minoru Fujimoto and Yoichiro Moriya and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Yoshiyuki Ohsugi

84 papers receiving 3.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yoshiyuki Ohsugi Japan	31	1.3k	1.1k	1.1k	767	481	84	4.0k
Y Ohsugi Japan	20	1.0k 0.8×	1.1k 1.0×	1.1k 1.0×	555 0.7×	292 0.6×	38	3.1k
Włodzimierz Maśliński Poland	35	1.8k 1.4×	1.4k 1.2×	656 0.6×	1.1k 1.5×	439 0.9×	150	4.4k
Masahiko Mihara Japan	40	2.3k 1.8×	1.6k 1.4×	1.3k 1.2×	1.6k 2.1×	783 1.6×	99	6.2k
Spiros Georgopoulos Greece	18	1.3k 1.0×	1.1k 1.0×	648 0.6×	788 1.0×	237 0.5×	23	3.5k
Gérald J. Prud’homme Canada	44	1.8k 1.4×	2.0k 1.8×	947 0.8×	393 0.5×	157 0.3×	119	5.6k
Jingwu Z. Zhang China	32	2.0k 1.5×	852 0.8×	671 0.6×	662 0.9×	148 0.3×	50	3.6k
Hitoshi Kohsaka Japan	36	1.5k 1.2×	1.2k 1.1×	586 0.5×	1.0k 1.3×	322 0.7×	158	4.0k
Sawsan Youssef United States	30	2.4k 1.9×	1.4k 1.2×	853 0.8×	663 0.9×	192 0.4×	46	5.2k
H. Daniel Perez United States	35	1.5k 1.2×	1.1k 1.0×	915 0.8×	211 0.3×	152 0.3×	87	3.5k
Horea Rus United States	43	2.8k 2.2×	1.5k 1.3×	433 0.4×	441 0.6×	447 0.9×	126	5.1k

Countries citing papers authored by Yoshiyuki Ohsugi

Since Specialization

Citations

This map shows the geographic impact of Yoshiyuki Ohsugi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshiyuki Ohsugi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshiyuki Ohsugi more than expected).

Fields of papers citing papers by Yoshiyuki Ohsugi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoshiyuki Ohsugi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshiyuki Ohsugi. The network helps show where Yoshiyuki Ohsugi may publish in the future.

Co-authorship network of co-authors of Yoshiyuki Ohsugi

This figure shows the co-authorship network connecting the top 25 collaborators of Yoshiyuki Ohsugi. A scholar is included among the top collaborators of Yoshiyuki Ohsugi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoshiyuki Ohsugi. Yoshiyuki Ohsugi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Okada, Masaji, Yoko Kita, Noriko Kanamaru, et al.. (2011). Anti-IL-6 Receptor Antibody Causes Less Promotion of Tuberculosis Infection than Anti-TNF- Antibody in Mice. SHILAP Revista de lepidopterología. 2011. 1–9. 20 indexed citations

Terabe, Fumitaka, Minoru Fujimoto, Satoshi Serada, et al.. (2010). Comparative analysis of the effects of anti-IL-6 receptor mAb and anti-TNF mAb treatment on CD4+ T-cell responses in murine colitis. Inflammatory Bowel Diseases. 17(2). 491–502. 14 indexed citations

Mihara, Masahiko, Yoshiyuki Ohsugi, & Tadamitsu Kishimoto. (2009). Evidence for the role of Th17 cell inhibition in the prevention of autoimmune diseases by anti‐interluekin‐6 receptor antibody. BioFactors. 35(1). 47–51. 26 indexed citations

Kuwamura, Mitsuru, Mitsuaki Moriyama, Masafumi Mukamoto, et al.. (2008). Neuritogenic Effects of T Cell-Derived IL-3 on Mouse Splenic Sympathetic Neurons In Vivo. The Journal of Immunology. 180(6). 4227–4234. 7 indexed citations

Mihara, Masahiko, Makoto Okazaki, Akito Nakamura, et al.. (2005). Tocilizumab inhibits signal transduction mediated by both mIL-6R and sIL-6R, but not by the receptors of other members of IL-6 cytokine family. International Immunopharmacology. 5(12). 1731–1740. 258 indexed citations

Ohsugi, Yoshiyuki, et al.. (2005). . Folia Pharmacologica Japonica. 126(6). 419–425. 6 indexed citations

Yamashita, Toru, Kazunobu Sawamoto, Shigeaki Suzuki, et al.. (2005). Blockade of interleukin‐6 signaling aggravates ischemic cerebral damage in mice: possible involvement of Stat3 activation in the protection of neurons. Journal of Neurochemistry. 94(2). 459–468. 150 indexed citations

Katsume, Asao, Hiroyuki Saito, Yoshiki Yamada, et al.. (2002). ANTI-INTERLEUKIN 6 (IL-6) RECEPTOR ANTIBODY SUPPRESSES CASTLEMAN'S DISEASE LIKE SYMPTOMS EMERGED IN IL-6 TRANSGENIC MICE. Cytokine. 20(6). 304–311. 112 indexed citations

Mihara, Masahiko, Norihiro Nishimoto, Yasuhiro Oda, et al.. (2001). Humanized Antibody to Human Interleukin-6 Receptor Inhibits the Development of Collagen Arthritis in Cynomolgus Monkeys. Clinical Immunology. 98(3). 319–326. 79 indexed citations

10.

Takagi, Nobuhiro, Masahiko Mihara, Yoichiro Moriya, et al.. (1998). Blockage of interleukin-6 receptor ameliorates joint disease in murine collagen-induced arthritis. Arthritis & Rheumatism. 41(12). 2117–2121. 11 indexed citations

11.

Yoshioka, Tatsunobu, Naoki Okada, Hajime MIYAMOTO, et al.. (1997). Development of novel drug delivery system of bioactive molecules from "cytomedicine" using hybridoma cells entrapped in alginate-poly(L) lysine-alginate microcapsules.. Drug Delivery System. 12(2). 107–114. 1 indexed citations

12.

Okada, Naoki, Hajime MIYAMOTO, Tatsunobu Yoshioka, et al.. (1997). Cytomedical therapy for IgG1 plasmacytosis in human interleukin-6 transgenic mice using hybridoma cells microencapsulated in alginate-poly(l) lysine-alginate membrane. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1360(1). 53–63. 23 indexed citations

13.

Okada, Naoki, Hajime MIYAMOTO, Tatsunobu Yoshioka, et al.. (1997). Immunological Studies of SK2 Hybridoma Cells Microencapsulated with Alginate-Poly(L)lysine-Alginate (APA) Membrane Following Allogeneic Transplantation. Biochemical and Biophysical Research Communications. 230(3). 524–527. 28 indexed citations

14.

Oka, Masaaki, Norio Iizuka, Kohtaro Yamamoto, et al.. (1996). The Influence of Interleukin-6 on the Growth of Human Esophageal Cancer Cell Lines. Journal of Interferon & Cytokine Research. 16(12). 1001–1006. 42 indexed citations

15.

Suzuki, Hiroshi, Kiyoshi Yasukawa, Takashi Saito, et al.. (1992). Anti‐human interleukin‐6 receptor antibody inhibits human myeloma growth in vivo. European Journal of Immunology. 22(8). 1989–1993. 87 indexed citations

16.

Mihara, Masahiko, Toshiaki Nakano, & Yoshiyuki Ohsugi. (1987). An immunomodulating anti-rheumatic drug, lobenzarit disodium (CCA): Inhibition of polyclonal B-cell activation and prevention of autoimmune disease in MRL/Mp-lpr/lpr mice. Clinical Immunology and Immunopathology. 45(3). 366–374. 12 indexed citations

17.

Kaiho, Shin-ichi, et al.. (1985). Anti-oxidative actions of Lobenzarit disodium (CCA).. Ensho. 5(1). 37–40. 3 indexed citations

18.

Ohsugi, Yoshiyuki & M. Eric Gershwin. (1984). Inhibition by various antiarthritic agents of murine splenic B cell colony formation. Immunopharmacology. 7(1). 1–7. 3 indexed citations

19.

Hata, Shun-ichi, Yoshiyuki Ohsugi, Toshiaki Nakano, et al.. (1983). AN ANTI-OXIDATIVE AND IMMUNOMODULATING ACTIONS OF NEW ANTI-ARTHRITIC AGENT, CCA (LOBENZARIT DISODIUM). Journal of Pharmacobio-Dynamics. 6(3). 1 indexed citations

20.

Ohsugi, Yoshiyuki, Takashi Matsuno, & Yoshio Takagaki. (1977). Mechanism of action of an anti-allergic compound; 2,4-bis(2-acetoxybenzamido)benzoic acid (AB50): Inhibition of anaphylactic and non-anaphylactic histamine release from rat peritoneal mast cells.. Chemical and Pharmaceutical Bulletin. 25(9). 2437–2443. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact